Nuclear medicine communications
-
The aim of this study was to validate the effectiveness of delayed risk stratification (DRS) in predicting structural progression and compare the predictive value of American Thyroid Association (ATA) risk stratification with that of DRS in patients with differentiated thyroid cancer (DTC). ⋯ DRS is superior to ATA risk stratification in predicting structural disease progression for DTC patients.